Made O'Meter
Ontdek waar een merk of product vandaan komt
Trosyd is a well-established medicated antifungal brand widely used to treat fungal nail infections (onychomycosis) and skin mycoses, containing the active substance tioconazole. The brand was originally researched and developed by the American multinational pharmaceutical corporation Pfizer in the late 1970s and early 1980s.
Over the years, rights to the brand across various European markets changed hands. In Northern Europe and Scandinavia, marketing and commercial distribution were handled through companies such as Galenica and Meda. Following international corporate consolidation, Meda was acquired by Mylan, which subsequently merged with Upjohn (a former Pfizer division) to form Viatris Inc., headquartered in the United States. In certain other markets, rights to the Trosyd brand name are held or marketed by regional pharmaceutical companies such as Giuliani in Italy.
For the Swedish and wider European consumer pharmacy market, Trosyd nail lacquer solution is typically manufactured in pharmaceutical facilities in Italy. Today, Viatris remains the ultimate corporate parent overseeing the distribution and commercial rights of the Trosyd formulation in Sweden.
Meld een bug of geef feedback
Made O'Meter gebruikt AI-gestuurde analyse om de herkomst van de productie te schatten. Resultaten zijn niet altijd 100% nauwkeurig.
2025 i7even ApS Kopenhagen Denemarken - Alle rechten voorbehouden. Concepten en methoden die in deze app worden gebruikt, mogen niet zonder toestemming worden gereproduceerd